Ophthalmic Eye Drops Market Poised for Growth with Projected USD 25.9 Billion Value by 2034

Ophthalmic Eye Drops Market
Ophthalmic Eye Drops Market

The need for healthy vision is driving a booming market! The Ophthalmic Eye Drops Market is expected to surge to a staggering USD 25.8 billion by 2034, reflecting a steady growth trajectory. This translates to a projected Compound Annual Growth Rate (CAGR) of 4.7%. This growth comes on the heels of a strong year in 2024, with the market valued at USD 17.3 billion and experiencing a healthy 5.4% year-over-year growth.

The soaring cases of eye infections have been driving ophthalmic eye drop sales. While the report presents a positive outlook for growth, ongoing restrictions amid the COVID-19 outbreak might hamper sales.

Experience the Magic of Learning through PDF Samples.
https://www.futuremarketinsights.com/reports/sample/rep-gb-13140

New eye drop product launches, branded as well as generic, are expected to be hampered in the short term due to disruptions in the supply chain, delayed pipeline research and development, and a shift in the priority of leading healthcare companies to COVID-19 vaccine and treatment developments.

According to the report, institutional sales of ophthalmic eye drops will rise considerably in the coming years. It will account for over half of ophthalmic eye drops sold through the forecast period.

“Increasing prevalence of eye infections, technological advancements, and high risk of infections from the increasing use of contact lens is expected to boost the growth of the ophthalmic eye drops market.” says the FMI Analyst

Key Takeaways from Ophthalmic Eye Drops Market Study

  • Ophthalmic eye drops market will expand consistently to surpass a valuation of US$ 15 Bn by 2021
  • The U.S. holds over 92.1% share of the North American market, but Canada is projected to expand faster at around 4.0% CAGR
  • Rising cases of eye infection will drive sales in the U.K., enabling it to register 3.9% y-o-y growth in 2021
  • Rising willingness to spend on advanced eye care will drive sales in Germany and France
  • Expansion of the healthcare sector will emerge as the chief growth driver in China and Japan. Both countries will exhibit a high demand for dilation drops

Due to their increasingly active lifestyle and desire for better aesthetics, many people are shifting to contact lenses. However, many ocular infections are associated with the use of contact lenses. Each year in the United States, approximately 1 million eye infections occur related primarily to keratitis, a fungal infection of the cornea, and contact lens infections account for estimated direct costs of $175 million. In addition, 40.9 million U.S. adults wear contact lenses, and 99% of 4,269 contact lens wearers were reported at least one contact lens–related hygiene behavior associated with an increased risk for eye infection or inflammation. Nearly a million eye infections requiring a trip to the doctor happen each year, many of them related to contact lens use.

Who is Winning?

The top players are focusing on increasing acquisitions at the regional level. Acquisitions empower the company with products and increase the company’s portfolio. The company acquires other players to possess well-established products and solutions that are expected to become a good revenue source for the acquirer. Acquisitions also enable the company to enter new emerging markets as well as enhance its presence in existing markets. Furthermore, key market players such as Novartis and Gerresheimer AG are focusing on the expansion of their market reach in different regions. For example-

  • In November 2020, Gerresheimer Regensburg announced that it is expanding its production area in Germany. The company has planned the expansion of its production capacity in small batch production, as a result of increasing development projects for pharmaceutical and medical technology products.
  • In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited, strengthening its position in the world’s third-largest generics market.

Some of the key market players covered by FMI include Novartis AG, Bausch & Lomb, Akorn, Inc., Biomedica, AdvaCare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN GROUP, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Gerresheimer AG, Adelphi Healthcare Packaging, Aptar Group Inc., and Amcor Plc.

Ophthalmic Eye Drops Market by Category Drug Class

  • Anesthetic Drops
  • Dilation Drops
  • Glaucoma Drops
  • Steroid Drops
  • Antibiotic Drops
  • Others (Antihistamines, Lubricants Tear Drops)

Indication

  • Dry Eye
  • Eye Allergy
  • Glaucoma
  • Eye Infection
  • Retinal Disorders
    • Macular Degeneration
    • Diabetic Retinopathy
    • Others
  • Uveitis
  • Others

Drug Formulation

  • With Preservative
  • Preservative Free

Container Type

  • Single Dose Container
  • Multiple-Dose Container

Distribution Channel

  • Institutional Sales
    • Hospitals
    • Community Clinics
    • Ophthalmic Clinics
    •  Public Health Agencies
    • Veterinary Hospitals & Clinics
  • Retail Sales
    • Retail Pharmacies
    •  Drug Stores

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel, and End Use over the next 10-years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these